doctors are worried about prescribing glp 1 As Demand for GLP-1 Weight Loss Drugs Grows, Some Worry Vulnerable Groups Weight-loss doctor reveals how GLP-1

Patients taking levothyroxine (if they have developed hypothyroidism post-treatment for Graves' disease) should take it consistently, ideally on an empty stomach in the morning, and thyroid function should be monitored to ensure adequate replacement

Orforglipron significantly reduced HbA1c to 2.1% in a phase II clinical trial assessing its use in T2DM, while dulaglutide achieved 1.1% and a placebo achieved 0.43% [106]

Controlled trials are needed to study this

Thus, a young man with ED rooted in performance anxiety might use PT-141 on a few occasions to break the cycle of worry and failure, restoring confidence